Since the inception of Modern Trader, a core editorial theme has centered on the wisdom and power of crowds. Editorial emphasis has focused on companies and projects engaged in the collection and analysis of information.
Thursday, 8 December 2016
Last updated 11 hours ago
Dec 20 2006 | 11:42am ET
A consortium of private equity heavyweights has agreed to pay $10.9 billion for medical device manufacturer Biomet.
The group includes the Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts and Texas Pacific Group.
Warsaw, Ind.-based Biomet designs and manufactures musculoskeletal medical products. The deal, which offers $44 per share and was unanimously approved by Biomet’s board, awaits shareholder approval.